Drug Shortage Report for DEXTROSE INJECTION USP
Report ID | 91585 |
Drug Identification Number | 02468514 |
Brand name | DEXTROSE INJECTION USP |
Common or Proper name | DEXTROSE INJECTION |
Company Name | PFIZER CANADA ULC |
Market Status | |
Active Ingredient(s) | DEXTROSE |
Strength(s) | 500 mg/mL |
Dosage form(s) | Solution |
Route of administration | Intravenous |
Packaging size | 10 X 50ml ANSYR |
ATC code | B05BA |
ATC description | I.V. Solutions |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-08-14 |
Estimated end date | |
Actual end date | 2020-01-29 |
Shortage status | Resolved |
Updated date | 2020-01-30 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2020-01-30 | French | Compare |
v4 | 2020-01-30 | English | Compare |
v3 | 2019-08-15 | English | Compare |
v2 | 2019-08-14 | French | Compare |
v1 | 2019-08-14 | English | Compare |
Showing 1 to 5 of 5